Ken Griffin En V Veno Medical Corp Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in En V Veno Medical Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 49,300 shares of NVNO stock, worth $258,825. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,300
Previous 22,000
124.09%
Holding current value
$258,825
Previous $113,000
137.17%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding NVNO
# of Institutions
37Shares Held
4.05MCall Options Held
274KPut Options Held
17.8K-
Kingdon Capital Management, L.L.C. New York, NY654KShares$3.43 Million0.43% of portfolio
-
Perceptive Advisors LLC New York, NY623KShares$3.27 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA574KShares$3.01 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT496KShares$2.6 Million0.17% of portfolio
-
Act Capital Management, LLC Wayne, PA401KShares$2.11 Million3.48% of portfolio
About enVVeno Medical Corp
- Ticker NVNO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 9,469,850
- Market Cap $49.7M
- Description
- enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...